Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 45.8%
Negative

Positive
Zacks Investment Research
3 days ago
Why Is IQVIA (IQV) Up 6.4% Since Last Earnings Report?
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
Why Is IQVIA (IQV) Up 6.4% Since Last Earnings Report?
Positive
Seeking Alpha
18 days ago
Oakmark Global Concentrated Strategy Q3 2025 Top Contributors And Detractors
Alibaba Group was a contributor during the quarter. The stock price rose significantly following earnings that reflected rapid Chinese AI growth. Alphabet was a contributor during the quarter. The stock price appreciated following a favorable ruling in the Google Search antitrust case and Q2 earnings that exceeded expectations across the board. Charter Communications was a detractor during the quarter. The broadband leader's stock price declined after it reported weak second-quarter earnings.
Oakmark Global Concentrated Strategy Q3 2025 Top Contributors And Detractors
Neutral
Seeking Alpha
19 days ago
IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript
IQVIA Holdings Inc. ( IQV ) UBS Global Healthcare Conference 2025 November 11, 2025 12:30 PM EST Company Participants Ari Bousbib - CEO & Chairman Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Presentation Daniel Leonard UBS Investment Bank, Research Division All right. We're live.
IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript
Positive
Seeking Alpha
23 days ago
Oakmark Concentrated Strategy: 6 Stocks That Raised Guidance And Drove Innovation
Warner Bros Discovery reported merger with Paramount-Skydance could generate meaningful cost synergies and create a scaled competitor with a deep and unmatched content library. Innovations in the Google Search experience are driving both engagement and revenue benefits for Alphabet. IQVIA's R&D solutions business showed signs of gaining share, with its win rate improving significantly.
Oakmark Concentrated Strategy: 6 Stocks That Raised Guidance And Drove Innovation
Neutral
Business Wire
24 days ago
Dr. William G. Kaelin Jr. joins IQVIA Board of Directors
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr. William G. Kaelin Jr. to its board of directors, effective today. Dr. Kaelin is a Senior Physician-Scientist at Brigham and Women's Hospital in Boston and the Sidney Farber Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School. He is also an Investigator at the Ho.
Dr. William G. Kaelin Jr. joins IQVIA Board of Directors
Positive
Zacks Investment Research
25 days ago
IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy?
Neutral
Zacks Investment Research
1 month ago
IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say
Positive
Zacks Investment Research
1 month ago
IQVIA Earnings & Revenues Beat Estimates in Q3, Increase Y/Y
IQV posts stronger-than-expected third-quarter 2025 earnings and revenue gains. It lifts the full-year guidance as all key segments show growth momentum.
IQVIA Earnings & Revenues Beat Estimates in Q3, Increase Y/Y
Neutral
Seeking Alpha
1 month ago
IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE:IQV ) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDT Company Participants Kerri Joseph - SVP of Investment Relation & Treasury Ari Bousbib - CEO & Chairman Ronald Bruehlman - Executive VP & CFO Michael Fedock - Senior Vice President of Financial Planning and Analysis Conference Call Participants David Windley - Jefferies LLC, Research Division Justin Bowers - Deutsche Bank AG, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Shlomo Rosenbaum - Stifel, Nicolaus & Company, Incorporated, Research Division Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Jeffrey Garro - Stephens Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing by.
IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates
IQVIA Holdings (IQV) came out with quarterly earnings of $3 per share, beating the Zacks Consensus Estimate of $2.96 per share. This compares to earnings of $2.84 per share a year ago.
IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates